1. Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC‐0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor. Issue 6 (23rd March 2018) Authors: Herman, Ann E.; Chinn, Leslie W.; Kotwal, Shweta G.; Murray, Elaine R.; Zhao, Rui; Florero, Marilyn; Lin, Alyse; Moein, Anita; Wang, Rena; Bremer, Meire; Kokubu, Serika; Serone, Adrian P.; Hanze, Eva L.; Viberg, Anders; Morimoto, Alyssa M.; Winter, Helen R.; Katsumoto, Tamiko R. Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 6(2018) Page Start: 1020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗